Betamethasone Versus Ketorolac Injection for the Treatment of DeQuervains Tenosynovitis

Inclusion Criteria: * Diagnosis of DeQuervain tendinopathy * Understands the local language and is willing and able to follow the requirements of the protocol * Understands the informed consent and signs the institutional review board/independent ethics committee (IRB/IEC) approved informed consent form Exclusion Criteria: * Patients who have an allergy to lidocaine, celestone, or ketorolac, nonsteroidal anti-inflammatory drugs (NSAIDs), or acetylsalicylic acid (ASA) * Patients who have an adverse reaction to lidocaine, celestone, or ketorolac (such as severe elevation of blood sugars in diabetics that caused medical complication) * Patients who have received a prior steroid injection within the past three months * Patients who have had a prior ipsilateral surgery for DeQuervain Tenosynovitis * Patients that have a skin lesion at the location of injection (such as trauma, eczema, rash) * Patients who have a current infection at the location of injection * Patients who have had iontophoresis within three months * Patients who are breast feeding, pregnant, or who plan to become pregnant in the next six months